In addition, NDRG1 is affected by not only the tumor microenvironment but also glioma treatments such as radiation, chemotherapeutic agents, and steroids, and its pathway is the mechanistic target of the rapamycin C2 (mTORC2)/SGK1 pathway [21]. This evidence concerns the gene C2 and central nervous system cancer.